Youmanitarian
Youmanitarian 11 Jun 2021

Up next

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
24 May 2023
Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
uchetex · 12 Views

Olaparib in Ovarian Cancer

16 Views
TAKE ACTION
Donations would go to support charities for #HEALTHCARE / Ovarian Cancer

In this segment, Bradley J. Monk, MD; Robert L. Coleman, MD; and Angeles Alvarez Secord, MD, examine the role of poly-ADP ribose polymerase (PARP) inhibitor, olaparib, in the treatment of advanced ovarian cancer.

Show more
More ways to take action
Explore ways that you can help bring a solution to this issue.

Up next

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
24 May 2023
Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
uchetex · 12 Views